Truxima is a Rituxan biosimlar therapy that targets CD20 protein antigens on B-cells, a type of white blood cell.
When B cells find an infection or other foreign invader in your body, they trigger the release of antibodies meant to destroy germs and viruses.
Although B-cells play a vital role in your immune system, they can become infected and fight against your body. Non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic Leukemia (CLL) are blood cancers that alter B-Cells, causing them to fight against your own body.
It is unclear exactly how Rituxan works, but researchers believe that other white blood cells to attack infected B cells through recruiting macrophages or by causing antibody- dependent cellular toxicity.
While effective when used a longside other cancer treatments, Truxima is also shown to be effective in treating a variety of autoimmune diseases through limiting the amount of overactive B-cells that are attacking healthy tissues in the body.
As prescribed by a physician
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.